Townsend DM and Tew KD: The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene. 22:7369–7375. 2003. View Article : Google Scholar : PubMed/NCBI

Chatterjee A and Gupta S: The multifaceted role of glutathione S-transferases in cancer. Cancer Lett. 433:33–42. 2018. View Article : Google Scholar : PubMed/NCBI

Eaton DL and Bammler TK: Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci. 49:156–164. 1999. View Article : Google Scholar : PubMed/NCBI

Ladner JE, Parsons JF, Rife CL, Gilliland GL and Armstrong RN: Parallel evolutionary pathways for glutathione transferases: Structure and mechanism of the mitochondrial class kappa enzyme rGSTK1-1. Biochemistry. 43:352–361. 2004. View Article : Google Scholar : PubMed/NCBI

Hayes JD, Flanagan JU and Jowsey IR: Glutathione transferases. Annu Rev Pharmacol Toxicol. 45:51–88. 2005. View Article : Google Scholar : PubMed/NCBI

Jakobsson PJ, Morgenstern R, Mancini J, Ford-Hutchinson A and Persson B: Common structural features of MAPEG - a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism. Protein Sci. 8:689–692. 1999. View Article : Google Scholar : PubMed/NCBI

Board PG, Coggan M, Chelvanayagam G, Easteal S, Jermiin LS, Schulte GK, Danley DE, Hoth LR, Griffor MC, Kamath AV, et al: Identification, characterization, and crystal structure of the Omega class glutathione transferases. J Biol Chem. 275:24798–24806. 2000. View Article : Google Scholar : PubMed/NCBI

Miyanishi K, Takayama T, Ohi M, Hayashi T, Nobuoka A, Nakajima T, Takimoto R, Kogawa K, Kato J, Sakamaki S, et al: Glutathione S-transferase-pi overexpression is closely associated with K-ras mutation during human colon carcinogenesis. Gastroenterology. 121:865–874. 2001. View Article : Google Scholar : PubMed/NCBI

Morel F, Rauch C, Petit E, Piton A, Theret N, Coles B and Guillouzo A: Gene and protein characterization of the human glutathione S-transferase kappa and evidence for a peroxisomal localization. J Biol Chem. 279:16246–16253. 2004. View Article : Google Scholar : PubMed/NCBI

Nordgard SH, Ritchie MD, Jensrud SD, Motsinger AA, Alnaes GI, Lemmon G, Berg M, Geisler S, Moore JH, Lønning PE, et al: ABCB1 and GST polymorphisms associated with TP53 status in breast cancer. Pharmacogenet Genomics. 17:127–136. 2007. View Article : Google Scholar : PubMed/NCBI

Vasieva O: The many faces of glutathione transferase pi. Curr Mol Med. 11:129–139. 2011. View Article : Google Scholar : PubMed/NCBI

Hollman AL, Tchounwou PB and Huang HC: The Association between Gene-Environment Interactions and Diseases Involving the Human GST Superfamily with SNP Variants. Int J Environ Res Public Health. 13:3792016. View Article : Google Scholar : PubMed/NCBI

Bolt HM and Thier R: Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab. 7:613–628. 2006. View Article : Google Scholar : PubMed/NCBI

Pinheiro DS, Rocha Filho CR, Mundim CA, Júnior PM, Ulhoa CJ, Reis AA and Ghedini PC: Evaluation of glutathione S-transferase GSTM1 and GSTT1 deletion polymorphisms on type-2 diabetes mellitus risk. PLoS One. 8:e762622013. View Article : Google Scholar : PubMed/NCBI

Yin Z, Ivanov VN, Habelhah H, Tew K and Ronai Z: Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases. Cancer Res. 60:4053–4057. 2000.PubMed/NCBI

Singh S: Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death. Cancer Chemother Pharmacol. 75:1–15. 2015. View Article : Google Scholar

Salinas AE and Wong MG: Glutathione S-transferases - a review. Curr Med Chem. 6:279–309. 1999.PubMed/NCBI

Hayes JD and Pulford DJ: The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 30:445–600. 1995. View Article : Google Scholar : PubMed/NCBI

McIlwain CC, Townsend DM and Tew KD: Glutathione S-transferase polymorphisms: Cancer incidence and therapy. Oncogene. 25:1639–1648. 2006. View Article : Google Scholar : PubMed/NCBI

Hung RJ, van der Hel O, Tavtigian SV, Brennan P, Boffetta P and Hashibe M: Perspectives on the molecular epidemiology of aerodigestive tract cancers. Mutat Res. 592:102–118. 2005. View Article : Google Scholar : PubMed/NCBI

Schnekenburger M, Karius T and Diederich M: Regulation of epigenetic traits of the glutathione S-transferase P1 gene: From detoxification toward cancer prevention and diagnosis. Front Pharmacol. 5:1702014. View Article : Google Scholar : PubMed/NCBI

Brockmöller J, Cascorbi I, Kerb R and Roots I: Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res. 56:3915–3925. 1996.PubMed/NCBI

Cowell IG, Dixon KH, Pemble SE, Ketterer B and Taylor JB: The structure of the human glutathione S-transferase pi gene. Biochem J. 255:79–83. 1988. View Article : Google Scholar : PubMed/NCBI

Laborde E: Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death. Cell Death Differ. 17:1373–1380. 2010. View Article : Google Scholar : PubMed/NCBI

Moyer AM, Salavaggione OE, Wu TY, Moon I, Eckloff BW, Hildebrandt MA, Schaid DJ, Wieben ED and Weinshilboum RM: Glutathione s-transferase p1: Gene sequence variation and functional genomic studies. Cancer Res. 68:4791–4801. 2008. View Article : Google Scholar : PubMed/NCBI

Sau A, Pellizzari Tregno F, Valentino F, Federici G and Caccuri AM: Glutathione transferases and development of new principles to overcome drug resistance. Arch Biochem Biophys. 500:116–122. 2010. View Article : Google Scholar : PubMed/NCBI

Henderson CJ, McLaren AW, Moffat GJ, Bacon EJ and Wolf CR: Pi-class glutathione S-transferase: Regulation and function. Chem Biol Interact. 111-112:69–82. 1998. View Article : Google Scholar : PubMed/NCBI

Nelson WG, De Marzo AM, Deweese TL, Lin X, Brooks JD, Putzi MJ, Nelson CP, Groopman JD and Kensler TW: Preneoplastic prostate lesions: An opportunity for prostate cancer prevention. Ann N Y Acad Sci. 952:135–144. 2001. View Article : Google Scholar

Nelson WG, DeWeese TL and DeMarzo AM: The diet, prostate inflammation, and the development of prostate cancer. Cancer Metastasis Rev. 21:3–16. 2002. View Article : Google Scholar : PubMed/NCBI

Sawers L, Ferguson MJ, Ihrig BR, Young HC, Chakravarty P, Wolf CR and Smith G: Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines. Br J Cancer. 111:1150–1158. 2014. View Article : Google Scholar : PubMed/NCBI

Hagrman D, Goodisman J and Souid AK: Kinetic study on the reactions of platinum drugs with glutathione. J Pharmacol Exp Ther. 308:658–666. 2004. View Article : Google Scholar

Zhang J, Wu Y, Hu X, Wang B, Wang L, Zhang S, Cao J and Wang Z: GSTT1, GSTP1, and GSTM1 genetic variants are associated with survival in previously untreated metastatic breast cancer. Oncotarget. 8:105905–105914. 2017.PubMed/NCBI

Duvoix A, Schnekenburger M, Delhalle S, Blasius R, Borde-Chiché P, Morceau F, Dicato M and Diederich M: Expression of glutathione S-transferase P1-1 in leukemic cells is regulated by inducible AP-1 binding. Cancer Lett. 216:207–219. 2004. View Article : Google Scholar : PubMed/NCBI

Alqarni MH, Muharram MM and Labrou NE: Ligand-induced glutathione transferase degradation as a therapeutic modality: Investigation of a new metal-mediated affinity cleavage strategy for human GSTP1-1. Int J Biol Macromol. 116:84–90. 2018. View Article : Google Scholar : PubMed/NCBI

Pajaud J, Ribault C, Ben Mosbah I, Rauch C, Henderson C, Bellaud P, Aninat C, Loyer P, Morel F and Corlu A: Glutathione transferases P1/P2 regulate the timing of signaling pathway activations and cell cycle progression during mouse liver regeneration. Cell Death Dis. 6:e15982015. View Article : Google Scholar : PubMed/NCBI

Morceau F, Duvoix A, Delhalle S, Schnekenburger M, Dicato M and Diederich M: Regulation of glutathione S-transferase P1-1 gene expression by NF-kappaB in tumor necrosis factor alpha-treated K562 leukemia cells. Biochem Pharmacol. 67:1227–1238. 2004. View Article : Google Scholar : PubMed/NCBI

Duvoix A, Morceau F, Delhalle S, Schmitz M, Schnekenburger M, Galteau MM, Dicato M and Diederich M: Induction of apoptosis by curcumin: Mediation by glutathione S-transferase P1-1 inhibition. Biochem Pharmacol. 66:1475–1483. 2003. View Article : Google Scholar : PubMed/NCBI

Duvoix A, Delhalle S, Blasius R, Schnekenburger M, Morceau F, Fougère M, Henry E, Galteau MM, Dicato M and Diederich M: Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition. Biochem Pharmacol. 68:1101–1111. 2004. View Article : Google Scholar : PubMed/NCBI

Moscow JA, Fairchild CR, Madden MJ, Ransom DT, Wieand HS, O'Brien EE, Poplack DG, Cossman J, Myers CE and Cowan KH: Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 49:1422–1428. 1989.PubMed/NCBI

Mian OY, Khattab MH, Hedayati M, Coulter J, Abubaker-Sharif B, Schwaninger JM, Veeraswamy RK, Brooks JD, Hopkins L, Shinohara DB, et al: GSTP1 Loss results in accumulation of oxidative DNA base damage and promotes prostate cancer cell survival following exposure to protracted oxidative stress. Prostate. 76:199–206. 2016. View Article : Google Scholar :

Rahbar MH, Samms-Vaughan M, Ma J, Bressler J, Dickerson AS, Hessabi M, Loveland KA, Grove ML, Shakespeare-Pellington S, Beecher C, et al: Synergic effect of GSTP1 and blood manganese concentrations in Autism Spectrum Disorder. Res Autism Spectr Disord. 18:73–82. 2015. View Article : Google Scholar : PubMed/NCBI

Bhang SY, Cho SC, Kim JW, Hong YC, Shin MS, Yoo HJ, Cho IH, Kim Y and Kim BN: Relationship between blood manganese levels and children's attention, cognition, behavior, and academic performance--a nationwide cross-sectional study. Environ Res. 126:9–16. 2013. View Article : Google Scholar : PubMed/NCBI

Rahbar MH, Samms-Vaughan M, Lee M, Christian MA, Bressler J, Hessabi M, Grove ML, Shakespeare-Pellington S, Desai CC, Reece JA, et al: Interaction between manganese and GSTP1 in relation to autism spectrum disorder while controlling for exposure to mixture of lead, mercury, arsenic, and cadmium. Res Autism Spectr Disord. 55:50–63. 2018. View Article : Google Scholar

Wright LS, Kornguth SE, Oberley TD and Siegel FL: Effects of lead on glutathione S-transferase expression in rat kidney: A dose-response study. Toxicol Sci. 46:254–259. 1998.

Li C, Yang X, Xu M, Zhang J and Sun N: Association between GSTP1 CpG methylation and the early phase of lead exposure. Toxicol Mech Methods. 24:111–115. 2014. View Article : Google Scholar

Kwong YL and Todd D: Delicious poison: Arsenic trioxide for the treatment of leukemia. Blood. 89:3487–3488. 1997. View Article : Google Scholar : PubMed/NCBI

Liu J, Chen H, Miller DS, Saavedra JE, Keefer LK, Johnson DR, Klaassen CD and Waalkes MP: Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol Pharmacol. 60:302–309. 2001. View Article : Google Scholar : PubMed/NCBI

Parker LJ, Bocedi A, Ascher DB, Aitken JB, Harris HH, Lo Bello M, Ricci G, Morton CJ and Parker MW: Glutathione transferase P1-1 as an arsenic drug-sequestering enzyme. Protein Sci. 26:317–326. 2017. View Article : Google Scholar

González-Martínez F, Sánchez-Rodas D, Cáceres DD, Martínez MF, Quiñones LA and Johnson-Restrepo B: Arsenic exposure, profiles of urinary arsenic species, and polymorphism effects of glutathione-s-transferase and metallothioneins. Chemosphere. 212:927–936. 2018. View Article : Google Scholar : PubMed/NCBI

Zhou L, Jing Y, Styblo M, Chen Z and Waxman S: Glutathione-S-transferase pi inhibits As₂O₃-induced apoptosis in lymphoma cells: Involvement of hydrogen peroxide catabolism. Blood. 105:1198–1203. 2005. View Article : Google Scholar

Van Dyck E, Nazarov PV, Muller A, Nicot N, Bosseler M, Pierson S, Van Moer K, Palissot V, Mascaux C, Knolle U, et al: Bronchial airway gene expression in smokers with lung or head and neck cancer. Cancer Med. 3:322–336. 2014. View Article : Google Scholar : PubMed/NCBI

Krais AM, Mühlbauer KR, Kucab JE, Chinbuah H, Cornelius MG, Wei QX, Hollstein M, Phillips DH, Arlt VM and Schmeiser HH: Comparison of the metabolic activation of environmental carcinogens in mouse embryonic stem cells and mouse embryonic fibroblasts. Toxicol In Vitro. 29:34–43. 2015. View Article : Google Scholar

Gilliland FD, Harms HJ, Crowell RE, Li YF, Willink R and Belinsky SA: Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum. Cancer Res. 62:2248–2252. 2002.PubMed/NCBI

Xue B, Wu Y, Yin Z, Zhang H, Sun S, Yi T and Luo L: Regulation of lipopolysaccharide-induced inflammatory response by glutathione S-transferase P1 in RAW264.7 cells. FEBS Lett. 579:4081–4087. 2005. View Article : Google Scholar : PubMed/NCBI

Yi L, Li L, Yin J, Hu N, Li G and Ding D: Proteomics analysis of liver tissues from C57BL/6J mice receiving low-dose 137Cs radiation. Environ Sci Pollut Res Int. 23:2549–2556. 2016. View Article : Google Scholar

Yi L, Hu N, Yin J, Sun J, Mu H, Dai K and Ding D: Up-regulation of calreticulin in mouse liver tissues after long-term irradiation with low-dose-rate gamma rays. PLoS One. 12:e01826712017. View Article : Google Scholar : PubMed/NCBI

Lu M, Xia L, Luo D, Waxman S and Jing Y: Dual effects of glutathione-S-transferase pi on As₂O₃ action in prostate cancer cells: Enhancement of growth inhibition and inhibition of apoptosis. Oncogene. 23:3945–3952. 2004. View Article : Google Scholar : PubMed/NCBI

Fujikawa Y, Nampo T, Mori M, Kikkawa M and Inoue H: Fluorescein diacetate (FDA) and its analogue as substrates for Pi-class glutathione S-transferase (GSTP1) and their biological application. Talanta. 179:845–852. 2018. View Article : Google Scholar : PubMed/NCBI

Wang J, Ren JH, Lin B, Jing YK and Cheng MS: Advances of studies on glutathione-S-transferase π. Zhongguo Yaowu Huaxue Zazhi. 15:251–256. 2005.

Ranganathan S and Tew KD: Immunohistochemical localization of glutathione S-transferases alpha, mu, and pi in normal tissue and carcinomas from human colon. Carcinogenesis. 12:2383–2387. 1991. View Article : Google Scholar : PubMed/NCBI

Zhang R, Kang KA, Piao MJ, Kim KC, Zheng J, Yao CW, Cha JW, Maeng YH, Chang WY, Moon PG, et al: Epigenetic alterations are involved in the overexpression of glutathione S-transferase π-1 in human colorectal cancers. Int J Oncol. 45:1275–1283. 2014. View Article : Google Scholar : PubMed/NCBI

Ding XQ, Bi JH, Ma ZG, Jiang ZX, Xi JF, Liu PZ and Zhang B: Correlation of ERCC1 and GSTP1 expression in esophageal cancer tissue with platinum-based chemotherapy sensitivity as well as apoptosis and proliferation gene expression. Hainan Yixueyuan Xuebao. 23:103–107. 2017.

Song Y, Du Y, Zhou Q, Ma J, Yu J, Tao X and Zhang F: Association of GSTP1 Ile105Val polymorphism with risk of esophageal cancer: A meta-analysis of 21 case-control studies. Int J Clin Exp Med. 7:3215–3224. 2014.PubMed/NCBI

Pljesa-Ercegovac M, Savic-Radojevic A, Dragicevic D, Mimic-Oka J, Matic M, Sasic T, Pekmezovic T, Vuksanovic A and Simic T: Enhanced GSTP1 expression in transitional cell carcinoma of urinary bladder is associated with altered apoptotic pathways. Urol Oncol. 29:70–77. 2011. View Article : Google Scholar

Savic-Radojevic A, Mimic-Oka J, Pljesa-Ercegovac M, Opacic M, Dragicevic D, Kravic T, Djokic M, Micic S and Simic T: Glutathione S-transferase-P1 expression correlates with increased antioxidant capacity in transitional cell carcinoma of the urinary bladder. Eur Urol. 52:470–477. 2007. View Article : Google Scholar : PubMed/NCBI

Gao L, Fang YQ, Zhang TY, Ge B, Xu B, Huang JF, Zhang ZF and Tan N: GSTP1 arrests bladder cancer T24 cells in G0/G1 phase and up-regulates p21 expression. Int J Clin Exp Med. 7:2984–2991. 2014.PubMed/NCBI

Oguztuzun Serpil, Ergün Duygu, Kilic Murat, Bozer Busra, Simsek Gulcin Güler and Bulus Hakan: The expression of GST and CYP isoenzymes in thyroid nodular hyperplasia and papillary thyroid cancer tissue: Correlation with clinical parameters. Entomol Appl Sci Lett. 5:97–103. 2016.

Dong X, Yang Y, Zhou Y, Bi X, Zhao N, Zhang Z, Li L, Hang Q, Zhang R, Chen D, et al: Glutathione S-transferases P1 protects breast cancer cell from adriamycin-induced cell death through promoting autophagy. Cell Death Differ. 26:2086–2099. 2019. View Article : Google Scholar : PubMed/NCBI

Liu X, Tan N, Liao H, Pan G, Xu Q, Zhu R, Zou L, He S and Zhu H: High GSTP1 inhibits cell proliferation by reducing Akt phosphorylation and is associated with a better prognosis in hepatocellular carcinoma. Oncotarget. 9:8957–8971. 2017.

Depeille P, Cuq P, Passagne I, Evrard A and Vian L: Combined effects of GSTP1 and MRP1 in melanoma drug resistance. Br J Cancer. 93:216–223. 2005. View Article : Google Scholar : PubMed/NCBI

Lin C, Xie L, Lu Y, Hu Z and Chang J: miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells. Int J Mol Med. 41:2050–2058. 2018.PubMed/NCBI

Zong C, Wang J and Shi TM: MicroRNA 130b enhances drug resistance in human ovarian cancer cells. Tumour Biol. 35:12151–12156. 2014. View Article : Google Scholar : PubMed/NCBI

Uchida Y, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Kawahara K, Nishiyama K, Seki N and Nakagawa M: MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines. Urol Oncol. 31:115–123. 2013. View Article : Google Scholar

Mutallip M, Nohata N, Hanazawa T, Kikkawa N, Horiguchi S, Fujimura L, Kawakami K, Chiyomaru T, Enokida H, Nakagawa M, et al: Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133α in head and neck squamous cell carcinoma (HNSCC). Int J Mol Med. 27:345–352. 2011.

Zhu J, Zhang R, Yang D, Li J, Yan X, Jin K, Li W, Liu X, Zhao J, Shang W, et al: Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1. Cell Physiol Biochem. 51:113–128. 2018. View Article : Google Scholar : PubMed/NCBI

Zhang X, Zhu J, Xing R, Tie Y, Fu H, Zheng X and Yu B: miR-513a-3p sensitizes human lung adenocarcinoma cells to chemotherapy by targeting GSTP1. Lung Cancer. 77:488–494. 2012. View Article : Google Scholar : PubMed/NCBI

Song X, Wang R, Xiao F, Zhang SX, Gong M, Wang XL, Zhang Y and Huang JY: Expressions of glutathione S-transferase P1 and 4-hydroxynonenal and the progression of prostate cancer. Zhonghua Nan Ke Xue. 23:412–416. 2017.In Chinese.

Singh S, Shukla GC and Gupta S: MicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer. Curr Pharmacol Rep. 1:79–88. 2015. View Article : Google Scholar : PubMed/NCBI

Kanwal R, Pandey M, Bhaskaran N, Maclennan GT, Fu P, Ponsky LE and Gupta S: Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1. Mol Carcinog. 53:8–18. 2014. View Article : Google Scholar :

Miyake T, Nakayama T, Naoi Y, Yamamoto N, Otani Y, Kim SJ, Shimazu K, Shimomura A, Maruyama N, Tamaki Y, et al: GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer. Cancer Sci. 103:913–920. 2012. View Article : Google Scholar : PubMed/NCBI

Gurioli G, Martignano F, Salvi S, Costantini M, Gunelli R and Casadio V: GSTP1 methylation in cancer: A liquid biopsy biomarker? Clin Chem Lab Med. 56:702–717. 2018. View Article : Google Scholar : PubMed/NCBI

Li Y, Cai Y, Chen H and Mao L: Clinical significance and association of GSTP1 hypermethylation with hepatocellular carcinoma: A meta-analysis. J Cancer Res Ther. 14(Suppl): S486–S489. 2018. View Article : Google Scholar : PubMed/NCBI

Li QF, Li QY, Gao AR and Shi QF: Correlation between promoter methylation in the GSTP1 gene and hepatocellular carcinoma development: A meta-analysis. Genet Mol Res. 14:6762–6772. 2015. View Article : Google Scholar : PubMed/NCBI

Jain S, Chen S, Chang KC, Lin YJ, Hu CT, Boldbaatar B, Hamilton JP, Lin SY, Chang TT, Chen SH, et al: Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma. PLoS One. 7:e357892012. View Article : Google Scholar : PubMed/NCBI

Qu Z, Jiang Y, Li H, Yu DC and Ding YT: Detecting abnormal methylation of tumor suppressor genes GSTP1, P16, RIZ1, and RASSF1A in hepatocellular carcinoma and its clinical significance. Oncol Lett. 10:2553–2558. 2015. View Article : Google Scholar : PubMed/NCBI

Gao S, Sun FK, Fan YC, Shi CH, Zhang ZH, Wang LY and Wang K: Aberrant GSTP1 promoter methylation predicts short-term prognosis in acute-on-chronic hepatitis B liver failure. Aliment Pharmacol Ther. 42:319–329. 2015. View Article : Google Scholar : PubMed/NCBI

Costa VL, Henrique R and Jerónimo C: Epigenetic markers for molecular detection of prostate cancer. Dis Markers. 23:31–41. 2007. View Article : Google Scholar : PubMed/NCBI

Goering W, Kloth M and Schulz WA: DNA methylation changes in prostate cancer. Methods Mol Biol. 863:47–66. 2012. View Article : Google Scholar : PubMed/NCBI

Maldonado L, Brait M, Loyo M, Sullenberger L, Wang K, Peskoe SB, Rosenbaum E, Howard R, Toubaji A, Albadine R, et al: GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer. J Urol. 192:1542–1548. 2014. View Article : Google Scholar : PubMed/NCBI

Zelic R, Fiano V, Zugna D, Grasso C, Delsedime L, Daniele L, Galliano D, Pettersson A, Gillio-Tos A, Merletti F, et al: Global Hypomethylation (LINE-1) and Gene-Specific Hypermethylation (GSTP1) on Initial Negative Prostate Biopsy as Markers of Prostate Cancer on a Rebiopsy. Clin Cancer Res. 22:984–992. 2016. View Article : Google Scholar

Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh WS, Isaacs WB and Nelson WG: Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA. 91:11733–11737. 1994. View Article : Google Scholar : PubMed/NCBI

Haluskova J, Lachvac L and Nagy V: The investigation of GSTP1, APC and RASSF1 gene promoter hypermethylation in urine DNA of prostate-diseased patients. Bratisl Lek Listy. 116:79–82. 2015.PubMed/NCBI

Lee JS: GSTP1 promoter hypermethylation is an early event in breast carcinogenesis. Virchows Arch. 450:637–642. 2007. View Article : Google Scholar : PubMed/NCBI

Alnaes GI, Ronneberg JA, Kristensen VN and Tost J: Heterogeneous DNA Methylation Patterns in the GSTP1 Promoter Lead to Discordant Results between Assay Technologies and Impede Its Implementation as Epigenetic Biomarkers in Breast Cancer. Genes (Basel). 6:878–900. 2015. View Article : Google Scholar

Miyake T, Nakayama T, Kagara N, Yamamoto N, Nakamura Y, Otani Y, Uji K, Naoi Y, Shimoda M, Maruyama N, et al: Association of GSTP1 methylation with aggressive phenotype in ER-positive breast cancer. Anticancer Res. 33:5617–5623. 2013.PubMed/NCBI

Muggerud AA, Rønneberg JA, Wärnberg F, Botling J, Busato F, Jovanovic J, Solvang H, Bukholm I, Børresen-Dale AL, Kristensen VN, et al: Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res. 12:R32010. View Article : Google Scholar : PubMed/NCBI

Feng W, Shen L, Wen S, Rosen DG, Jelinek J, Hu X, Huan S, Huang M, Liu J, Sahin AA, et al: Correlation between CpG methylation profiles and hormone receptor status in breast cancers. Breast Cancer Res. 9:R572007. View Article : Google Scholar : PubMed/NCBI

Sunami E, Shinozaki M, Sim MS, Nguyen SL, Vu AT, Giuliano AE and Hoon DS: Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors. Breast Cancer Res. 10:R462008. View Article : Google Scholar : PubMed/NCBI

Song B, Wang L, Zhang Y, Li N, Dai H, Xu H, Cai H and Yan J: Combined Detection of HER2, Ki67, and GSTP1 Genes on the Diagnosis and Prognosis of Breast Cancer. Cancer Biother Radiopharm. 34:85–90. 2019. View Article : Google Scholar

Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y and Motoyama T: Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci. 94:589–592. 2003. View Article : Google Scholar : PubMed/NCBI

Russo AL, Thiagalingam A, Pan H, Califano J, Cheng KH, Ponte JF, Chinnappan D, Nemani P, Sidransky D and Thiagalingam S: Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin Cancer Res. 11:2466–2470. 2005. View Article : Google Scholar : PubMed/NCBI

Vaissière T, Hung RJ, Zaridze D, Moukeria A, Cuenin C, Fasolo V, Ferro G, Paliwal A, Hainaut P, Brennan P, et al: Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res. 69:243–252. 2009. View Article : Google Scholar : PubMed/NCBI

Haroun RA, Zakhary NI, Mohamed MR, Abdelrahman AM, Kandil EI and Shalaby KA: Assessment of the prognostic value of methylation status and expression levels of FHIT, GSTP1 and p16 in non-small cell lung cancer in Egyptian patients. Asian Pac J Cancer Prev. 15:4281–4287. 2014. View Article : Google Scholar : PubMed/NCBI

Drilon A, Sugita H, Sima CS, Zauderer M, Rudin CM, Kris MG, Rusch VW and Azzoli CG: A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage I to IIIA non-small-cell lung cancers. J Thorac Oncol. 9:1272–1277. 2014. View Article : Google Scholar : PubMed/NCBI

Kim DS, Cha SI, Lee JH, Lee YM, Choi JE, Kim MJ, Lim JS, Lee EB, Kim CH, Park TI, et al: Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population. Lung Cancer. 58:1–6. 2007. View Article : Google Scholar : PubMed/NCBI

Gumy-Pause F, Pardo B, Khoshbeen-Boudal M, Ansari M, Gayet-Ageron A, Sappino AP, Attiyeh EF and Ozsahin H: GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma. Genes Chromosomes Cancer. 51:174–185. 2012. View Article : Google Scholar

Ferraù F, Romeo PD, Puglisi S, Ragonese M, Spagnolo F, Salpietro C, Ientile R, Currò M, Visalli G, Alibrandi A, et al: GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly. J Endocrinol Invest. 2018.

Ali-Osman F, Akande O, Antoun G, Mao JX and Buolamwini J: Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 272:10004–10012. 1997. View Article : Google Scholar : PubMed/NCBI

Cote ML, Chen W, Smith DW, Benhamou S, Bouchardy C, Butkiewicz D, Fong KM, Gené M, Hirvonen A, Kiyohara C, et al: Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: A HuGE-GSEC review. Am J Epidemiol. 169:802–814. 2009. View Article : Google Scholar : PubMed/NCBI

Pérez-Ramírez C, Cañadas-Garre M, Alnatsha A, Villar E, Delgado JR, Calleja-Hernández MÁ and Faus-Dáder MJ: Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer. Pathol Res Pract. 214:44–52. 2018. View Article : Google Scholar

Saarikoski ST, Voho A, Reinikainen M, Anttila S, Karjalainen A, Malaveille C, Vainio H, Husgafvel-Pursiainen K and Hirvonen A: Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer. 77:516–521. 1998. View Article : Google Scholar : PubMed/NCBI

Li XM, Yu XW, Yuan Y, Pu MZ, Zhang HX, Wang KJ and Han XD: Glutathione S-transferase P1, gene-gene interaction, and lung cancer susceptibility in the Chinese population: An updated meta-analysis and review. J Cancer Res Ther. 11:565–570. 2015. View Article : Google Scholar : PubMed/NCBI

Tarek F: Role of glutathione S-transferase P-1 (GSTP-1) gene polymorphism in COPD patients. Egypt J Chest Dis Tuberc. 65:739–744. 2016. View Article : Google Scholar

Lakhdar R, Denden S, Knani J, Leban N, Daimi H, Hassine M, Lefranc G, Ben Chibani J and Haj Khelil A: Relationship between glutathione S-transferase P1 polymorphisms and chronic obstructive pulmonary disease in a Tunisian population. Genet Mol Res. 9:897–907. 2010. View Article : Google Scholar : PubMed/NCBI

Wang Y, Ren BU, Zhang L and Guo Z: Correlation between metabolic enzyme GSTP1 polymorphisms and susceptibility to lung cancer. Exp Ther Med. 10:1521–1527. 2015. View Article : Google Scholar : PubMed/NCBI

He L, Gao L, Shi Z, Li Y, Zhu L, Li S, Zhang P, Zheng G, Ren Q, Li Y, et al: Involvement of cytochrome P450 1A1 and glutathione S-transferase P1 polymorphisms and promoter hypermethylation in the progression of anti-tuberculosis drug-induced liver injury: A case-control study. PLoS One. 10:e01194812015. View Article : Google Scholar : PubMed/NCBI

Qu K, Liu SS, Wang ZX, Huang ZC, Liu SN, Chang HL, Xu XS, Lin T, Dong YF and Liu C: Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients. World J Gastroenterol. 21:4310–4322. 2015. View Article : Google Scholar : PubMed/NCBI

Song QB, Wang Q and Hu WG: A systemic review of glutathione S-transferase P1 Ile105Val polymorphism and colorectal cancer risk. Chin J Cancer Res. 26:255–267. 2014.PubMed/NCBI

Lei Z, Liu T, Li X, Xu X and Fan D: Contribution of glutathione S-transferase gene polymorphisms to development of skin cancer. Int J Clin Exp Med. 8:377–386. 2015.PubMed/NCBI

Lira MG, Provezza L, Malerba G, Naldi L, Remuzzi G, Boschiero L, Forni A, Rugiu C, Piaserico S, Alaibac M, et al: Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients. Exp Dermatol. 15:958–965. 2006. View Article : Google Scholar : PubMed/NCBI

Gsur A, Haidinger G, Hinteregger S, Bernhofer G, Schatzl G, Madersbacher S, Marberger M, Vutuc C and Micksche M: Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int J Cancer. 95:152–155. 2001. View Article : Google Scholar : PubMed/NCBI

Harries LW, Stubbins MJ, Forman D, Howard GC and Wolf CR: Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 18:641–644. 1997. View Article : Google Scholar : PubMed/NCBI

Chen ZH, Xian JF and Luo LP: Association between GSTM1, GSTT1, and GSTP1 polymorphisms and gastric cancer risk, and their interactions with environmental factors. Genet Mol Res. 16:gmr160188772017. View Article : Google Scholar

Nguyen TV, Janssen MJ, van Oijen MG, Bergevoet SM, te Morsche RH, van Asten H, Laheij RJ, Peters WH and Jansent JB: Genetic polymorphisms in GSTA1, GSTP1, GSTT1, and GSTM1 and gastric cancer risk in a Vietnamese population. Oncol Res. 18:349–355. 2010. View Article : Google Scholar : PubMed/NCBI

Negovan A, Iancu M, Moldovan V, Mocan S and Banescu C: The Interaction between GSTT1, GSTM1, and GSTP1 Ile105Val Gene Polymorphisms and Environmental Risk Factors in Premalignant Gastric Lesions Risk. BioMed Res Int. 2017:73650802017. View Article : Google Scholar :

Tripathi S, Ghoshal U, Ghoshal UC, Mittal B, Krishnani N, Chourasia D, Agarwal AK and Singh K: Gastric carcinogenesis: Possible role of polymorphisms of GSTM1, GSTT1, and GSTP1 genes. Scand J Gastroenterol. 43:431–439. 2008. View Article : Google Scholar : PubMed/NCBI

Jiao L, Bondy ML, Hassan MM, Chang DZ, Abbruzzese JL, Evans DB, Smolensky MH and Li D: Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer. Cancer. 109:840–848. 2007. View Article : Google Scholar : PubMed/NCBI

Liu S, Yi Z, Ling M, Shi J, Qiu Y and Yang S: Predictive potential of ABCB1, ABCC3, and GSTP1 gene polymorphisms on osteosarcoma survival after chemotherapy. Tumour Biol. 35:9897–9904. 2014. View Article : Google Scholar : PubMed/NCBI

Wei L, Song XR, Wang XW, Li M and Zuo WS: Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance. Zhonghua Zhong Liu Za Zhi. 28:445–448. 2006.In Chinese. PubMed/NCBI

Zhang SL, Mao NF, Sun JY, Shi ZC, Wang B and Sun YJ: Predictive potential of glutathione S-transferase polymorphisms for prognosis of osteosarcoma patients on chemotherapy. Asian Pac J Cancer Prev. 13:2705–2709. 2012. View Article : Google Scholar : PubMed/NCBI

Yang LM, Li XH and Bao CF: Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors. Asian Pac J Cancer Prev. 13:5883–5886. 2012. View Article : Google Scholar

Ben Ami T, Sarig O, Sprecher E and Goldberg I: Glutathione S-transferase polymorphisms in patients with photosensitive and non-photosensitive drug eruptions. Photodermatol Photoimmunol Photomed. 35:214–220. 2019. View Article : Google Scholar : PubMed/NCBI

Rajesh D, Balakrishna S, Azeem Mohiyuddin SM, Suryanarayana R and Kutty AVM: Novel association of oral squamous cell carcinoma with GSTP1 Arg187Trp gene polymorphism. J Cell Biochem. 120:5906–5912. 2019. View Article : Google Scholar

Dunna NR, Vuree S, Kagita S, Surekha D, Digumarti R, Rajappa S and Satti V: Association of GSTP1 gene (I105V) polymorphism with acute leukaemia. J Genet. 91:e60–e63. 2012.PubMed/NCBI

Allan JM, Wild CP, Rollinson S, Willett EV, Moorman AV, Dovey GJ, Roddam PL, Roman E, Cartwright RA and Morgan GJ: Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci USA. 98:11592–11597. 2001. View Article : Google Scholar : PubMed/NCBI

Daraki A, Zachaki S, Rosmaraki F, Kalomoiraki M, Aleporou-Marinou V, Sambani C, Kollia P and Manola KN: Association of GSTP1 inactivating polymorphism with acute myeloid leukemia and its specific chromosomal abnormalities. Leuk Lymphoma. 58:2505–2507. 2017. View Article : Google Scholar : PubMed/NCBI

Bănescu C, Iancu M, Trifa AP, Cândea M, Benedek Lazar E, Moldovan VG, Duicu C, Tripon F, Crauciuc A and Dobreanu M: From Six Gene Polymorphisms of the Antioxidant System, Only GPX Pro198Leu and GSTP1 Ile105Val Modulate the Risk of Acute Myeloid Leukemia. Oxid Med Cell Longev. 2016:25367052016. View Article : Google Scholar

Bănescu C, Trifa AP, Voidăzan S, Moldovan VG, Macarie I, Benedek Lazar E, Dima D, Duicu C and Dobreanu M: CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 genetic polymorphisms in chronic myeloid leukemia: A case-control study. Oxid Med Cell Longev. 2014:8758612014. View Article : Google Scholar

He HR, Zhang XX, Sun JY, Hu SS, Ma Y, Dong YL and Lu J: Glutathione S-transferase gene polymorphisms and susceptibility to chronic myeloid leukemia. Tumour Biol. 35:6119–6125. 2014. View Article : Google Scholar : PubMed/NCBI

Sailaja K, Surekha D, Rao DN, Rao DR and Vishnupriya S: Association of the GSTP1 gene (Ile105Val) polymorphism with chronic myeloid leukemia. Asian Pac J Cancer Prev. 11:461–464. 2010.PubMed/NCBI

Kasznicki J, Kosmalski M, Sliwinska A, Mrowicka M, Stanczyk M, Majsterek I and Drzewoski J: Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy. Mol Biol Rep. 39:8669–8678. 2012. View Article : Google Scholar : PubMed/NCBI

Stoian A, Bănescu C, Bălaşa RI, Moţăţăianu A, Stoian M, Moldovan VG, Voidăzan S and Dobreanu M: Influence of GSTM1, GSTT1, and GSTP1 Polymorphisms on Type 2 Diabetes Mellitus and Diabetic Sensorimotor Peripheral Neuropathy Risk. Dis Markers. 2015:6386932015. View Article : Google Scholar : PubMed/NCBI

Qiu YH, Xu YL and Zhang WH: Effect of GSTM1, GSTT1, and GSTP1 IIe105Val polymorphisms on susceptiblity to gestational diabetes mellitus. Genet Mol Res. 15:gmr.150277112016. View Article : Google Scholar

Mir O, Alexandre J, Tran A, Durand JP, Pons G, Treluyer JM and Goldwasser F: Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: Clinical evidence of a role of oxidative stress in taxane toxicity. Ann Oncol. 20:736–740. 2009. View Article : Google Scholar : PubMed/NCBI

Gajewska B, Kaźmierczak B, Kuźma-Kozakiewicz M, Jamrozik Z and Barańczyk-Kuźma A: GSTP1 Polymorphisms and their Association with Glutathione Transferase and Peroxidase Activities in Patients with Motor Neuron Disease. CNS Neurol Disord Drug Targets. 14:1328–1333. 2015. View Article : Google Scholar : PubMed/NCBI

Pastor S, Rodríguez-Ribera L, Corredor Z, da Silva Filho MI, Hemminki K, Coll E, Försti A and Marcos R: Levels of DNA damage (Micronuclei) in patients suffering from chronic kidney diseaseRole of GST polymorphisms. Mutat Res Genet Toxicol Environ Mutagen. 836(Pt A): 41–46. 2018. View Article : Google Scholar : PubMed/NCBI

Agusa T, Kunito T, Tue NM, Lan VT, Fujihara J, Takeshita H, Minh TB, Trang PT, Takahashi S, Viet PH, et al: Individual variations in arsenic metabolism in Vietnamese: The association with arsenic exposure and GSTP1 genetic polymorphism. Metallomics. 4:91–100. 2012. View Article : Google Scholar

Stoyanova E, Pastor S, Coll E, Azqueta A, Collins AR and Marcos R: Base excision repair capacity in chronic renal failure patients undergoing hemodialysis treatment. Cell Biochem Funct. 32:177–182. 2014. View Article : Google Scholar

Lok HC, Suryo Rahmanto Y, Hawkins CL, Kalinowski DS, Morrow CS, Townsend AJ, Ponka P and Richardson DR: Nitric oxide storage and transport in cells are mediated by glutathione S-transferase P1-1 and multidrug resistance protein 1 via dinitrosyl iron complexes. J Biol Chem. 287:607–618. 2012. View Article : Google Scholar :

Suryo Rahmanto Y, Kalinowski DS, Lane DJ, Lok HC, Richardson V and Richardson DR: Nitrogen monoxide (NO) storage and transport by dinitrosyl-dithiol-iron complexes: Long-lived NO that is trafficked by interacting proteins. J Biol Chem. 287:6960–6968. 2012. View Article : Google Scholar : PubMed/NCBI

Lok HC, Sahni S, Richardson V, Kalinowski DS, Kovacevic Z, Lane DJ and Richardson DR: Glutathione S-transferase and MRP1 form an integrated system involved in the storage and transport of dinitrosyldithiolato iron complexes in cells. Free Radic Biol Med. 75:14–29. 2014. View Article : Google Scholar : PubMed/NCBI

Lok HC, Sahni S, Jansson PJ, Kovacevic Z, Hawkins CL and Richardson DR: A Nitric Oxide Storage and Transport System That Protects Activated Macrophages from Endogenous Nitric Oxide Cytotoxicity. J Biol Chem. 291:27042–27061. 2016. View Article : Google Scholar : PubMed/NCBI

Kovacevic Z, Sahni S, Lok H, Davies MJ, Wink DA and Richardson DR: Regulation and control of nitric oxide (NO) in macrophages: Protecting the "professional killer cell" from its own cytotoxic arsenal via MRP1 and GSTP1. Biochim Biophys Acta, Gen Subj. 1861(5 Pt A): 995–999. 2017. View Article : Google Scholar

Cao X, Kong X, Zhou Y, Lan L, Luo L and Yin Z: Glutathione S-transferase P1 suppresses iNOS protein stability in RAW264.7 macrophage-like cells after LPS stimulation. Free Radic Res. 49:1438–1448. 2015. View Article : Google Scholar : PubMed/NCBI

Zhang B, Jing C, Li X and Wang J: Effect of 1-octyl-3-methyl-imidazolium bromide on the expressions of CYP1A1, CYP1A2, CYP3A4, and GSTP1, and the receptors AhR, ARNT, and PXR in HepG2 cells. J Toxicol Toxin Rev. 34:72015. View Article : Google Scholar

Kim Y, Maciag AE, Cao Z, Deschamps JR, Saavedra JE, Keefer LK and Holland RJ: PABA/NO lead optimization: Improved targeting of cytotoxicity to glutathione S-transferase P1-overexpressing cancer cells. Bioorg Med Chem. 23:4980–4988. 2015. View Article : Google Scholar : PubMed/NCBI

Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD, Pincus MR, Sardana M, Henderson CJ, Wolf CR, et al: Regulation of JNK signaling by GSTp. EMBO J. 18:1321–1334. 1999. View Article : Google Scholar : PubMed/NCBI

Wang T, Arifoglu P, Ronai Z and Tew KD: Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J Biol Chem. 276:20999–21003. 2001. View Article : Google Scholar : PubMed/NCBI

Tew KD and Townsend DM: Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification. Drug Metab Rev. 43:179–193. 2011. View Article : Google Scholar : PubMed/NCBI

Okamura T, Antoun G, Keir ST, Friedman H, Bigner DD and Ali-Osman F: Phosphorylation of Glutathione S-Transferase P1 (GSTP1) by Epidermal Growth Factor Receptor (EGFR) Promotes Formation of the GSTP1-c-Jun N-terminal kinase (JNK) Complex and Suppresses JNK Downstream Signaling and Apoptosis in Brain Tumor Cells. J Biol Chem. 290:30866–30878. 2015. View Article : Google Scholar : PubMed/NCBI

Elsby R, Kitteringham NR, Goldring CE, Lovatt CA, Chamberlain M, Henderson CJ, Wolf CR and Park BK: Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi. J Biol Chem. 278:22243–22249. 2003. View Article : Google Scholar : PubMed/NCBI

Yin ZM, Liu AH and Jiang Y: Glutathione S-transferase pi Protects Serum Depletion-induced Cell Death by Inhibiting ASK1-MKK7-JNK Pathway in the 293 Cells. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 33:185–190. 2001.

Liu X, An BH, Kim MJ, Park JH, Kang YS and Chang M: Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator. Biochem Biophys Res Commun. 452:840–844. 2014. View Article : Google Scholar : PubMed/NCBI

Sun KH, Chang KH, Clawson S, Ghosh S, Mirzaei H, Regnier F and Shah K: Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity. J Neurochem. 118:902–914. 2011. View Article : Google Scholar : PubMed/NCBI

Wan Hasan WN, Kwak MK, Makpol S, Wan Ngah WZ and Mohd Yusof YA: Piper betle induces phase I & II genes through Nrf2/ARE signaling pathway in mouse embryonic fibroblasts derived from wild type and Nrf2 knockout cells. BMC Complement Altern Med. 14:722014. View Article : Google Scholar :